$27.16 $0.90 per serving
Product analysis
Ultimate Omega Lemon supplies EPA and DHA that may modestly support joint comfort over repeated use. Its omega-3 cost compares favorably.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
EPA and DHA are named, but their identities do not establish the oil’s precise structure. A special absorption advantage cannot be assumed.
Ingredient Transparency78
Amounts and the omega-3 breakdown are disclosed. Other listed forms are unspecified, while the main fatty acids remain easy to compare.
Value For Money80
The EPA and DHA comparison suggests favorable value. The fatty-acid amount provides a more meaningful comparison than total fish-oil weight.
Customer Satisfaction92
Customer ratings are strongly favorable. A large review pool makes the satisfaction pattern more established without proving health effects.
Product Focus75
Omega-3 links the joint, skin and metabolism goals. Joint support may be modest with repeated use, while skin and metabolic effects vary by preparation and individual circumstances.
- Format
Softgel - Container
- 60 Softgel(s)
- Per serving
- $0.90
- Also available
Ultimate Omega Lemon$64.56- Customer rating
- 4.8 · 7,883 ratings
Goals
Impact
High effect
Omega-3 · 1280 mg
EPA and DHA may modestly support joint comfort and function in people with osteoarthritis or inflammatory joint pain over repeated use. Findings vary across preparations and populations, and some large trials found no benefit. The declared serving only partly matches the saved amount references; it does not establish prevention or better results at higher intake.
How this product is rated for Joint Health
Ingredient fit78
EPA and DHA account for the relevant ingredient focus. The declared fatty-acid amounts partly meet the comparison references; total oil mass is not interchangeable with EPA and DHA.
Goal fit
EPA and DHA account for the relevant ingredient focus.
Dose adequacy
The declared fatty-acid amounts partly meet the comparison references; total oil mass is not interchangeable with EPA and DHA.
Pathways40
EPA and DHA contribute mainly to inflammation-related joint comfort, with variable symptom evidence.
Depth
EPA and DHA contribute mainly to inflammation-related joint comfort, with variable symptom evidence.
Breadth
Only inflammation-related support reached the saved coverage requirement; broad joint support was not established.
Evidence69
EPA and DHA have mixed evidence, with small average symptom improvements alongside null trials. The saved preparation check accepts the declared fatty acids, without establishing that all oil preparations have equivalent effects.
Evidence strength
EPA and DHA have mixed evidence, with small average symptom improvements alongside null trials.
Studied preparation
The saved preparation check accepts the declared fatty acids, without establishing that all oil preparations have equivalent effects.
Formulation logic100
No missing ingredient partner requirement was identified. None of the evaluated ingredient conflicts was identified.
Partner coverage
No missing ingredient partner requirement was identified.
Conflicts
None of the evaluated ingredient conflicts was identified.
Effective doses
All included ingredients reach the saved minimum amount requirement; that does not establish a clinically effective regimen.
Impact
High effect
Omega-3 · 1280 mg
Omega-3 has mixed findings for resting energy use: a small study in older women found an increase, while a study in young men did not. These population differences limit expectations of a general metabolism boost. The declared omega-3 amount is considered separately from total fish-oil mass.
How this product is rated for Metabolism Support
Ingredient fit81
Omega-3 account for the main retained ingredient links. Amount recognition is distinct from proof of a metabolism boost.
Goal fit
Omega-3 supplies the main retained ingredient connection.
Dose adequacy
Known amounts receive partial comparison recognition; the comparison is not a proven dose-response for increased calorie use.
Pathways43
The retained connection concerns insulin sensitivity and metabolic hormones; mixed population findings limit any calorie-burning interpretation.
Depth
The retained connection concerns insulin sensitivity and metabolic hormones; mixed population findings limit any calorie-burning interpretation.
Breadth
One pathway reaches the saved coverage threshold; broader thermogenic coverage is not established.
Evidence89
Omega-3 supplies the strongest retained evidence connection, with conflicting resting-metabolic-rate findings across populations.
Evidence strength
Omega-3 supplies the strongest retained evidence connection, with conflicting resting-metabolic-rate findings across populations.
Studied preparation
Eligible ingredients meet the saved preparation criteria; this does not establish increased energy expenditure from the exact product.
Formulation logic100
No unmet required partner or configured conflict was identified. The amount threshold does not establish extra effects from combining ingredients.
Partner coverage
The retained ingredients have no unmet required partner in the supplied findings; this does not establish extra benefit from their combination.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
The eligible ingredients meet the saved amount threshold, which does not establish a clinically effective metabolism-boosting dose.
Impact
High effect
Omega-3 · 1280 mg
Omega-3 supplies fatty acids relevant to skin barrier lipids, the main contribution recognized here. Its disclosed serving amount meets or approaches the saved amount criteria. Generic omega-3 cannot inherit findings from specific purified EPA preparations used in UV-challenge studies, so routine hydration or UV benefits remain uncertain.
How this product is rated for Skin Health
Ingredient fit96
The formula contains ingredients relevant to skin nutrition. Their amounts and the presence of other actives determine how focused this finding is.
Goal fit
The relevant ingredients dominate the formula, although the product is linked to several goals.
Dose adequacy
The ingredients included in this finding meet the saved amount criteria; this does not establish extra benefit from larger amounts.
Pathways50
The strongest recorded coverage concerns epidermal barrier lipids; this describes the saved finding, not a demonstrated clinical effect.
Depth
The strongest recorded coverage concerns epidermal barrier lipids; this describes the saved finding, not a demonstrated clinical effect.
Breadth
One skin mechanism reaches the coverage threshold; support across other mechanisms remains limited.
Evidence78
Omega-3 provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Evidence strength
Omega-3 provides the strongest recognized evidence contribution, subject to the ingredient-specific population and preparation limits.
Studied preparation
The saved result accepts the relevant preparations, although this does not establish that the finished product matches a skin trial.
Formulation logic100
The included ingredients have no recorded missing partners or configured conflicts. Amount limitations are retained separately.
Partner coverage
No missing required ingredient partner limits the saved finding; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was identified in the supplied evaluation.
Effective doses
All ingredients included in this finding meet the saved minimum amount threshold, without proving a clinical response.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 20 Calorie(s) | |
Total Fat | 2 Gram(s) | |
Total Omega-3 Fatty Acids (Docosahexaenoic Acid, Eicosapentaenoic Acid, Other Omega-3 Fatty Acids) | 1280 mg | |
Cholesterol | 5 mg |
Omega-3 (Docosahexaenoic Acid, Eicosapentaenoic Acid, Other Omega-3 Fatty Acids) · 1280 mg OverallScore54
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
- Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
- Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
- Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
- A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
- Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
- Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
- Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
- The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
- A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
- Dietetic intervention in psoriatic arthritis: the DIETA trial.
- Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
- Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
- Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.